Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 9, 2008 - Issue 18
Submit an article Journal homepage
253
Views
21
CrossRef citations to date
0
Altmetric
Original research

Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial

Marianna Mazza Catholic University of Sacred Heart of Rome, Institute of Psychiatry and Psychology, Bipolar Disorders Unit, Via Ugo De Carolis, 48 00136 Roma, Italy +39 06 353 48285; +39 06 355 01909; [email protected]; [email protected]
, MD PhD,
Maria Rosaria Squillacioti Catholic University of Sacred Heart of Rome, Institute of Psychiatry and Psychology, Bipolar Disorders Unit, Via Ugo De Carolis, 48 00136 Roma, Italy +39 06 353 48285; +39 06 355 01909; [email protected]; [email protected]
, MD,
Riccardo Daniele Pecora Polo Ospedaliero SS. Trinità, Sora, ASL Frosinone, Italy
, MD,
Luigi Janiri Catholic University of Sacred Heart of Rome, Institute of Psychiatry and Psychology, Bipolar Disorders Unit, Via Ugo De Carolis, 48 00136 Roma, Italy +39 06 353 48285; +39 06 355 01909; [email protected]; [email protected]
, MD &
Pietro Bria Catholic University of Sacred Heart of Rome, Institute of Psychiatry and Psychology, Bipolar Disorders Unit, Via Ugo De Carolis, 48 00136 Roma, Italy +39 06 353 48285; +39 06 355 01909; [email protected]; [email protected]
, MD
Pages 3145-3149 | Published online: 04 Nov 2008

Bibliography

  • Mcintyre RS, Soczynska JK, Woldeyohannes HO, et al. Aripiprazole: pharmacology and evidence in bipolar disorder. Expert Opin Pharmacother 2007;8(7):1001-9
  • Aihara K, Shimada J, Miwa T, et al. The novel antipsychotic aripiprazole is a partial agonist at short and long isoforms of D2 receptors linked to the regulation of adenylyl cyclase activity and prolactin release. Brain Res 2004;1003(1-2):9-17
  • Mcintyre RS, Konarski JZ. Tolerability profiles of atypical antipsychotics in the treatment of bipolar disorder. J Clin Psychiatry 2005;66(Suppl 3):28-36
  • Kemp DE, Gilmer WS, Fleck J, et al. Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia. Prog. Neuropsychopharmacol. Biol Psychiatry 2007;31(2):574-7
  • Sokolski KN. Adjunctive aripiprazole in bipolar I depression. Ann Pharmacother 2007;41(1):35-40
  • Mcelroy SL, Suppes T, Frye MA, et al. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial. J Aff Disord 2007;101(1-3):275-81
  • Keck PE, Calabrese JR, Mcintyre RS, et al. The Aripiprazole Study Group. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. J Clin Psychiatry 2007;68:1480-91
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth edition. American Psychiatric Association, Washington, DC:1994
  • Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9
  • Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-35
  • First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV Axis I Disorders – Patient Edition (SCID - I/P, Version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute;1995
  • Tohen M, Vieta E, Calabrese JR, et al. Efficacy of olanzapine and olanzapine–fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003;60:1079-88
  • Calabrese JR, Keck PE Jr, Macfadden W, et al. A randomized double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005;162:1351-60
  • Thase ME, Jonas A, Khan A, et al. Aripiprazole monotherapy in non-psychotic bipolar I depression. Results of 2 randomized, placebo-controlled studies. J Clin Psychopharmacol 2008;28(1):13-20
  • Gentile S. Long-term treatment with atypical antipsychotics and the risk of weight gain: a literature analysis. Drug Saf 2006;29:303-19

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.